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CD4+CD25+Foxp3+ natural regulatory T cells 
(T reg cells) are essential for maintaining self-
tolerance (Kim et al., 2007; Sakaguchi et al., 
2008). The loss of these cells leads to a fatal 
autoimmune syndrome affecting multiple or-
gans (Sakaguchi et al., 1995; Kronenberg and 
Rudensky, 2005). In addition, these cells in-
terfere with the development of organ-specific 
autoimmune diseases, such as type 1 diabetes 
(Salomon et al., 2000; Tarbell et al., 2004; 
You  et  al.,  2008)  and  inflammatory  bowel 
disease (IBD), by silencing self-reactive Th1 
and Th17 cells (Powrie et al., 1993; Izcue et al., 
2006; Korn et al., 2007).
Several requirements for T reg cell homeo-
stasis in vivo have been defined. For example, 
T reg cells are IL-2 dependent and maintained 
by constant homeostatic division in response to 
self-antigens (Fisson et al., 2003; von Boehmer, 
2003; Setoguchi et al., 2005). In addition to 
self-antigen recognition, which is essential for 
their  activation  and  function  (Thornton  and 
Shevach, 1998; Samy et al., 2005), T reg cell 
survival in the periphery also requires co-stim-
ulation  through  the  CD28  and  B7  pathway 
(Salomon et al., 2000). Finally, actively divid-
ing T reg cells appear to be more suppressive 
than  those  that  are  quiescent  (Klein  et  al., 
2003). However, it is not known whether an-
tigen-presenting cells (and which ones, if any) 
are required for maintaining T reg cells in 
vivo in the steady state (Denning et al., 2007; 
Yamazaki et al., 2008).
DCs are specialized antigen-presenting cells 
that capture, process, and present antigens to 
T cells (Banchereau and Steinman, 1998). The 
outcome of the encounter between these two 
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CD4+CD25+Foxp3+ natural regulatory T cells (T reg cells) maintain self-tolerance and 
suppress autoimmune diseases such as type 1 diabetes and inflammatory bowel disease 
(IBD). In addition to their effects on T cells, T reg cells are essential for maintaining 
normal numbers of dendritic cells (DCs): when T reg cells are depleted, there is a compen-
satory Flt3-dependent increase in DCs. However, little is known about how T reg cell 
homeostasis is maintained in vivo. We demonstrate the existence of a feedback regulatory 
loop between DCs and T reg cells. We find that loss of DCs leads to a loss of T reg cells, 
and that the remaining T reg cells exhibit decreased Foxp3 expression. The DC-dependent 
loss in T reg cells leads to an increase in the number of T cells producing inflammatory 
cytokines, such as interferon  and interleukin 17. Conversely, increasing the number of 
DCs leads to increased T reg cell division and accumulation by a mechanism that requires 
major histocompatibility complex II expression on DCs. The increase in T reg cells induced 
by DC expansion is sufficient to prevent type 1 autoimmune diabetes and IBD, which 
suggests that interference with this feedback loop will create new opportunities for 
immune-based therapies.
© 2009 Darrasse-Jèze et al.  This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months  after  the  publication  date  (see  http://www.jem.org/misc/terms.shtml).   
After six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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effect on T reg cells (Fig. 1 A and Fig. S2). We conclude 
that the number of T reg cells is directly proportional to the 
number of DCs in vivo.
DC and T reg cell proliferation in vivo
To determine whether the increase in T reg cells in FL-
treated mice was caused by the conversion of Foxp3 cells to 
T reg cells (Apostolou and von Boehmer, 2004), we purified 
allotype-marked GFP T cells from FOXP3–diphtheria toxin 
receptor (DTR)–GFP mice (Kim et al., 2007) and adoptively 
transferred them to FL-treated recipients. Although we did 
find the expected increase of host T reg cells in response to 
FL, there was no detectable conversion of Foxp3 cells to 
T reg cells (Fig. S1 B). To ascertain whether the increase in   
T reg cells in response to FL was caused by T reg cell pro-
liferation, we monitored T reg cell division using CFSE 
dye dilution. Allotype-marked, CFSE-labeled T cells were 
adoptively transferred into WT, FL/, or FL-overexpressing 
mice. As reported by others, autoreactive T reg cells undergo 
constant homeostatic division in WT mice in the steady state 
(Fisson et al., 2003; von Boehmer, 2003). We found that this 
division was impaired in DC-deficient FL/ mice and in-
creased in FL-overexpressing mice that had increased num-
bers of DCs (Fig. 1 B). In contrast, CD4+ and CD8+ T cells 
show little homeostatic division, and this was not altered by 
loss or overexpression of FL (Fig. 1 B). In addition, the abso-
lute numbers of donor CFSE+ T reg cells that had not divided 
was the same irrespective of FL deficiency or overexpression. 
Therefore, FL did not alter these cells’ survival (Fig. 1 C). To 
determine whether the increase in T reg cell proliferation 
in mice treated with FL was a direct result of the effect of FL 
on T reg cells, we repeated the transfer experiment using 
FLr-deficient (FLr/) donor T cells (Mackarehtschian et al., 
1995). We found that FLr/ T reg cells were similar to WT 
T reg cells in that they showed increased proliferation in   
FL-treated mice compared with uninjected controls (Fig. 1 D). 
We conclude that natural T reg cell proliferation in vivo in-
creases with FL injection and decreases in its absence. However, 
FL does not have a direct effect on T reg cells, and therefore, FL 
effect is not T reg cell autonomous.
MHCII expression by DCs is required to sustain T reg cell 
proliferation in vivo
To determine whether the effects of FL were DC depen-
dent, we ablated CD11chi DCs by administration of DT in 
CD11c-DTR BM chimeras. Mice treated for 6 d with DT 
showed a reduction in the numbers of DCs in the spleen and 
LN, and a two- to threefold decrease in T reg cell numbers 
(Fig. 2 A and Fig. S3 A). This decrease in T reg cells was not 
the result of a decrease in T reg cell production in the thy-
mus (Fig. S3 B; Liston et al., 2008). In addition, adoptively 
transferred, CFSE-labeled, allotype-marked T reg cells showed 
a decrease in homeostatic division upon DC depletion (Fig. 2 B). 
We conclude that T reg cell homeostatic division in the LN 
and the spleen is dependent on the number of conventional 
DCs in those organs.
cell types depends on the activation status of the DC. In the 
steady state, antigen presentation by DCs leads to tolerance 
by T cell deletion, induction of anergy, or expansion of 
antigen-specific T reg cells (Brocker et al., 1997; Hawiger 
et al., 2001; Steinman and Nussenzweig, 2002; Hawiger et al., 
2004;  Kretschmer  et  al.,  2005;  Luckashenak  et  al.,  2008; 
Yamazaki et al., 2008). In contrast, antigen presentation by 
DCs that are activated or matured by Toll-like receptor li-
gands, CD40 ligation, Fc receptor signaling, or inflammatory 
cytokines leads to protective T cell immunity (Steinman and 
Nussenzweig, 2002). Given the importance of DCs for 
immune activation, it might be expected that the loss of these 
cells would lead to the absence of immune responses. How-
ever, congenital DC deficiency leads instead to a complex 
generalized lympho- and myeloproliferative syndrome with 
some  features  of  autoimmune  disease,  including  increased 
numbers of granulocytes, inflammatory mediators, and possi-
bly T reg cells (Birnberg et al., 2008; Ohnmacht et al., 2009). 
Additional clues that DCs are involved in T reg cell homeo-
stasis are given in the recent report that Flt3 ligand (FL) can 
expand T reg cells (Swee et al., 2009), and that loss of T reg 
cells increases DC division by a FL-dependent mechanism 
(Liu et al., 2009). Whether these effects on DCs result in di-
rect or indirect feedback changes in T reg cell homeostasis in 
vivo is not known (Birnberg et al., 2008). In this report, we 
examined whether DCs are required to maintain T reg cells 
in vivo and uncovered the existence of a feedback regulatory 
loop required to maintain physiological numbers of the two 
cell types in the steady state.
RESULTS AND DISCUSSION
Numbers of T reg cells correlate with DCs
T reg cell depletion results in increased numbers of DCs by 
an FL-dependent mechanism (Liu et al., 2009). Conversely, 
antigens delivered to peripheral DCs in the steady state can 
induce antigen-specific T reg cell development and expan-
sion, but the role of DCs in maintaining T reg cell homeo-
stasis in vivo has not been determined. To ascertain whether 
DCs are required to maintain T reg cell homeostasis in vivo, 
we examined FL-deficient mice (FL/ mice), which show 
a 10-fold reduction in the number of conventional DCs in 
the spleen and LN (Fig. 1 A; McKenna et al., 2000). We 
found a twofold reduction in the numbers of T reg cells 
(CD4+CD25+Foxp3+)  in  the  spleen  in  the  FL/  mice. 
Similar effects were obtained by treating mice with sunitinib 
(O’Farrell et al., 2003), an Flt3 receptor (FLr) inhibitor 
(Fig. 1 A). Conversely, increasing the numbers of DCs by 
injecting mice with soluble FL (Maraskovsky et al., 1996; 
Swee et al., 2009) or B16 melanoma cells secreting FL was 
associated with an increase in the number of T reg cells in 
the spleen (Fig. 1 A). Plotting the number of DCs versus 
T reg cells in all such experiments revealed a highly significant 
and correlated relationship between the two cell types, both 
in the spleen and the LN (Fig. 1 A and Fig. S1). Other lym-
phoid populations, such as CD4+ and CD8+ T cells, were 
much less affected, and B cell depletion had no measurable JEM VOL. 206, August 31, 2009  1855
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Figure 1.  Coordinate DC and T reg cell homeostasis. (A) Representative dot plots show the percentage of CD11chiMHCII+ cells (top) and Foxp3+CD25+ 
T reg cells (bottom) among CD3+CD4+ splenocytes. Numbers indicate percentages. C57BL/6 mice were untreated (WT), treated for 1 wk with sunitinib, injected 
with B16-FL tumor (B16FL), treated for 12 d with rmFL, or untreated FL/ mice. Bar graphs show corresponding mean percentages and absolute numbers ± SD 
(n = 4–12 mice in five experiments). Graphs (right) show nonlinear regression analysis of data shown in histograms, plotting the percentage or absolute 
numbers of DCs (y axis) versus T reg cells (x axis) in the spleen. (B) Histograms show representative CFSE dye dilution by CD45.1 congenic cells transferred into 
CD45.2 C57BL/6 control (WT), FL/, and B16-FL–injected mice evaluated in the spleen at the indicated times after transfer (top). Numbers indicate percent-
ages of cells that had undergone more than five divisions. (C) Graph shows absolute numbers ± SEM of splenic CD45.1+ donor T reg cells that had undergone 
zero, one to five, or more than five divisions 12 d after transfer into the indicated mice. Bar graphs in B and C summarize data (means ± SD; n = 4–6 mice in 
two independent experiments). (D) Dot plots show numbers of FLr+/+ CD45.1 (host) and FLr/ CD45.1 (donor) T reg cells in mice from day 4 to day 12 of 
treatment with FL or PBS. Bar graphs summarize the percentage and absolute number of donor and recipient T reg cells. Histograms show CFSE dilution in 
splenic FLr/ donor T reg cells 12 d after transfer (right; n = 3 mice per group in two experiments. p-values were determined by a Student’s t test comparing 
the experimental group versus WT. *, P < 0.05; **, P < 0.01; ***, P < 0.001. ns, nonstatistically significant.1856 DCS REGULATE T REG CELL HOMEOSTASIS AND TOLERANCE IN VIVO | Darrasse-Jèze et al.
and WT control, or MHCII/ cells. After DT treatment, 
CD11chiGFP+ cells expressing MHCII were deleted, leav-
ing WT MHCII+CD11c+ cells in CD11cDTR/WT→WT 
control  chimeras,  but  only  MHCII/CD11c+  DCs  in   
the CD11cDTR/MHCII/→WT chimeras (Fig. 2 C). 
Homeostatic T reg cell division is thought to require self-
antigen presentation by MHCII because it is impaired in 
MHCII/ mice (Shimoda et al., 2006). To determine whether 
these effects are mediated by DCs, we produced mixed BM 
chimeras composed of 4:1 mixtures of CD11c-GFP-DTR 
Figure 2.  MHCII expression by DC is required to maintain T reg cell homeostasis. (A) Dot plots show CD11c versus MHCII (top) and Foxp3 versus 
CD25 (bottom) staining in the spleens of CD11cDTR→WT chimeric mice after treatment with PBS or DT. Histograms show the means ± SD of the absolute 
number of endogenous DCs and T reg cells in spleens measured 12 d after PBS or DT treatment (n = 6 mice in one representative out of five experiments). 
(B) Histogram shows the mean numbers ± SD of CFSE-labeled transferred T reg cells that underwent more than five divisions in the spleens of the CD11-
DTR chimeras shown in A at the indicated time points after transfer (n = 3 mice for each condition in five experiments). (C) Dot plots show endogenous 
DCs and T reg cells in the spleens of the indicated chimeric mice treated with PBS or DT for 6 d. Histograms summarize the number of endogenous DCs 
and T reg cells ± SD, and the Foxp3 intensity of expression in T reg cells as measured by the mean fluorescence index difference (MFI) between T reg and 
CD4+Foxp3 cells ± SD (n = 2–3 mice per group in three experiments). (D) Histograms (left) show representative examples of day 7 CFSE dye dilution by 
transferred allotype-marked T reg cells in the experiments shown in C. Histograms (right) summarize the number of transferred CFSE-labeled T reg cells 
found in the spleens of the same mice (n = 2–3 mice in three experiments). (E) DCs (top) and T reg cells (middle) in the spleens of CD11c-Cre/I-Abflox+/ 
and CD11c-Cre/I-Abflox/ mice, and CFSE dye dilution by allotype-marked T reg cells after 7 d (bottom). Percentages and absolute numbers of endog-
enous T reg cells and CFSE donor T reg cells ± SEM are indicated (n = 3 mice per group). One representative out of two experiments is shown. p-values 
were determined by a Student’s t test comparing the experimental group versus control. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 206, August 31, 2009  1857
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mice by injection of CD4+CD25+ regulatory T cells six 
hours after each DT injection. We found that injection of 
T reg cells prevented the increase in IL-17 in the DT-treated 
CD11cDTR→WT chimeric mice (Fig. 3 D). Thus, DC-
deficient mice show decreased numbers of T reg cells and 
increased levels of autoimmune inflammation that can be 
reversed by T reg cells.
DC-mediated increases in T reg cells prevent autoimmunity
To  determine  whether  increasing  the  numbers  of  DCs 
would prevent autoimmune diseases by increasing natural 
T  reg  cells,  we  measured  the  impact  of  increasing  DC 
numbers on type 1 diabetes in nonobese diabetic (NOD) 
mice and also in a model of IBD. FL injection protects 
NOD mice from type 1 diabetes (O’Keeffe et al., 2005), 
but the question of whether this effect is mediated by T reg 
cells has not yet been explored. To address the question of 
whether T reg cells might be involved in the FL-mediated 
protection from type 1 diabetes, we compared FL and FL+ 
anti-CD25–injected NOD mice. We found that protection 
from type 1 diabetes by FL in NOD mice was abrogated by 
anti-CD25, which suggests that the effect is T reg cell de-
pendent (Fig. 4 A). IBD was induced by injection of naive 
CD4+ T cells into RAG/ mice, leading to weight loss 
and gut inflammation (Powrie et al., 1993; Izcue et al., 
2006). Coinjection of T reg cells protected against the dis-
ease in a dose-dependent manner (Fig. 4, B–D). For exam-
ple, coinjection of 2 × 105 T reg cells with 5 × 105 CD4 
T cells was protective, but 2 × 104 or 2 × 103 T reg cells 
was not sufficient (Fig. 4, B–D; and not depicted). FL in-
creased the number of T reg cells in this model, but FL did 
not alter the course of the disease in the absence of T reg 
cells (Fig. 4, B–D) or in mice coinjected with 2 × 103 T reg 
cells (not depicted). However, the combination of FL with 
2 × 104 T reg cells, which was associated with an increase 
in T reg cells (Fig. 4 E and Fig. S4), prevented weight loss 
and IBD (Fig. 4, B–D), as well as other autoimmune mani-
festations, such as loss of fur (Fig. S4). Thus, increasing the 
number of T reg cells by increasing DCs can be protective 
against autoimmune diseases.
Our results reveal the existence of a previously unap-
preciated feedback regulatory loop that maintains the num-
ber of T reg cells and DCs in vivo. This regulatory circuit is 
likely to be essential to the balance between immunity and 
tolerance. Loss of T reg cells results in autoimmunity and an 
increase in the number of DCs (Kim et al., 2007; Liu et al., 
2009), which is mediated in part by FLr-induced DC divi-
sion in the secondary lymphoid organs (Waskow et al., 
2008). The experiments reported in this paper show that 
the increase in DCs, in turn, results in an expansion of T reg 
cells by a mechanism that requires DC expression of MHCII. 
This feedback loop would normally result in the reestablish-
ment of T reg cell numbers and immune balance (Fig. 5). 
Conversely, a loss of DCs results in a loss of T reg cells and 
an increased risk of autoimmune disease. However, under 
steady-state conditions, the decrease in T reg cells results in 
In both cases, MHCII continued to be expressed by radio-
resistant nonhematopoietic host cells as well as by CD11c 
donor cells. We found no change in T reg cell numbers 
after DT administration in CD11cDTR/WT→WT chime-
ras, whereas they were greatly reduced in CD11cDTR/
MHCII/→WT  chimeric  mice  (Fig.  2  C).  Moreover,   
allotype-marked CSFE-labeled T reg cells transferred into 
treated CD11cDTR/MHCII/→WT chimeric mice showed 
impaired proliferation compared with controls (Fig. 2 D). 
In addition, we observed that the remaining T reg cells in 
CD11cDTR/MHCII/→WT  DT-treated  chimeras  ex-
hibit  lower  Foxp3  levels  than  their  counterparts  from 
MHCII+/+ DC-sufficient mice, as illustrated by their dimin-
ished mean fluorescence index (Fig. 2 C). A similar effect 
was also observed in DC-deficient DT-treated CD11cDTR→
WT (Fig. 2 C) and FL/ mice (Fig. S1 C). This feature 
has been associated with decreased suppressive function   
of T reg cells and autoimmune disorders issues (Wan and 
Flavell, 2007).
T reg cell proliferation in response to cultured DCs 
appears to be MHCII independent (Swee et al., 2009). To 
confirm the role of MHCII expression by DCs in T reg 
cell homeostasis in vivo, we deleted MHCII specifically 
on CD11c cells in vivo by breeding mice that carry lox-p–
flanked MHC-II (I-Abflox; Hashimoto et al., 2002) with 
CD11c-Cre mice (Caton et al., 2007) to produce CD11c-
Cre/I-Abflox mice. CD11c-Cre/I-Abflox mice lacked MHCII 
expression on CD11chi cells (Fig. 2 E and Fig. S3 C) and re-
sembled  FL/  mice  and  CD11cDTR/MHCII/  chi-
meric mice treated with DT in that they harbored fewer   
T reg cells than littermate controls (Fig. 2 E and Fig. S3 C). 
In addition, the proliferation of transferred CFSE-labeled 
T  reg  cells  was  impaired  in  CD11c-Cre/I-Abflox  mice 
compared with controls (Fig. 2 E). We conclude that the   
DC-dependent feedback loop that controls T reg cell num-
bers and homeostatic division is dependent on MHCII expres-
sion by DCs in vivo.
Increase in Th1 and Th17 cells
To determine whether altering T reg cell homeostasis by 
decreasing the number of DCs has an impact on host im-
mune status, we measured the proportions of Th1 and Th17 
cells (Korn et al., 2009) in the lamina propria of the small 
intestine of CD11cDTR→WT chimeric mice treated with 
DT.  We  found  that  IFN-–  and  IL-17–expressing  cells 
were increased 5- and 2-fold, respectively, in the lamina 
propria and 10- and 2-fold, respectively, in the spleens of 
DT–treated CD11cDTR→WT chimeric mice but not in 
the CD11cDTR+WT→WT controls (Fig. 3, A and D). 
Similar results were obtained in DC-deficient FL/ mice 
(Fig. 3 B) and CD11cDTA mice (Ohnmacht et al., 2009). 
In addition, we measured the levels of IgG antibodies in 
the serum and found that FL/ mice developed a hyper-
gammaglobulinemia,  unlike  the  age-matched  WT  mice 
(Fig. 3 C). To determine whether these effects are caused 
by the loss of T reg cells, we complemented DC-depleted 1858 DCS REGULATE T REG CELL HOMEOSTASIS AND TOLERANCE IN VIVO | Darrasse-Jèze et al.
vated T cells can produce FL, the precise source of the FL 
that is responsible for this effect remains to be determined 
(Fichelson, 1998).
an FL-dependent increase in DCs, which leads to increased 
homeostatic expansion of T reg cells, which in turn leads to 
a return to immune equilibrium (Fig. 5). Although acti-
Figure 3.  Lack of T reg cells causes autoimmunity in DC-deficient mice. (A) Dot plots show representative examples of intracellular staining for 
IL-17 or IFN- in lamina propria CD3+CD4+ T cells from CD11cDTR→WT BM chimeras or CD11cDTR+WT→WT control mixed BM chimeras 12 d after treat-
ment with PBS or DT. Histograms summarize the results (n = 4 experiments with two to three mice per group) and show the numbers of IFN-+ and 
IL-17+ Th cells in the lamina propria after DC depletion. p-values were calculated by a Student’s t test. *, P < 0.05; **, P < 0.01. (B) Dot plots show intracellular 
staining for IL-17 and IFN- in CD3+CD4+TCR T cells and CD3+TCR+ T cells from the lamina propria of C57BL/6 and FL/ mice. Histograms show the 
percentages of Th1 and Th17 cells among the indicated population of T cells (n = 2 mice per group in two experiments). (C) Graph shows total serum IgG 
levels in FL/ () and B6 control () mice as determined by ELISA. Results are expressed as mean values ± SEM (n = 5 mice for each group). The experi-
ment was performed twice with similar results. (D) Dot plots show CD11c versus MHCII (top), Foxp3 versus CD25 (middle), and IL-17 versus IFN- (bot-
tom) expression by splenocytes (top) or CD4+ splenocytes (middle and bottom) from CD11c-DTR chimeric mice that received PBS, DT, or DT plus 8–10 × 106  
T reg cells every 3 d for 12 d. Histograms show the means ± SD of the proportions of the indicated populations (n = 3 mice in two experiments).  
A Student’s t test was used for statistical analysis. *, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM VOL. 206, August 31, 2009  1859
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for the emergence of compensatory mechanisms, which can 
confound any primary deficits. In addition, CD11c is ex-
pressed on macrophages, NK cells, epithelial cells, and many 
other leukocytes; therefore, the complex immune phenotype 
found in CD11c-Cre/ROSA-DTA mice may be caused 
by effects on cells other than DCs (Birnberg et al., 2008; 
Ohnmacht et al., 2009). The existence of a peripheral feed-
back circuit between DCs and T reg cells in vivo has signifi-
cant implications for immune-based therapies, as demonstrated 
by the effects of FL injection on the course of autoimmune 
diseases such as type 1 diabetes and IBD.
Our  results  differ  from  other  observations  in  mice  in 
which DCs and other CD11c-expressing cells were constitu-
tively depleted (Birnberg et al., 2008; Ohnmacht et al., 2009). 
In those experiments, there was a complex generalized lym-
pho- and myeloproliferative syndrome with some features 
of autoimmune disease, including increased numbers of 
granulocytes,  inflammatory  mediators,  and  possibly  T  reg 
cells (Ohnmacht et al., 2009). This discrepancy might be at-
tributable to the difference between acute versus chronic DC 
ablation in the CD11c-Cre/ROSA-DTA mice (Birnberg et al., 
2008; Ohnmacht et al., 2009). The chronic model allows 
Figure 4.  Effect of altered DC homeostasis on autoimmunity. (A) Protection of diabetes in FL-treated mice is abrogated by T reg cell depletion. The 
graph shows the incidence of diabetes over time in days in NOD mice treated with FL (green; n = 10) or PBS for 10 d (orange; n = 16; log-rank test differ-
ence, P < 0.01), or with anti-CD25 mAb injection before FL treatment (blue; n = 11 mice in two experiments). (B–E) Protection of colitis in mice treated 
with FL is T reg cell dependent. (B) Graph shows body weight at 16 wk relative to the initial weight of RAG/ mice (8 wk old) that receive no cells, or  
5 × 105 CD4+CD44intCD25 T cells alone or together with the indicated number of T reg cells with or without FL. Each dot represents an individual mouse 
(two experiments). (C) Colitis scores of the mice shown in B. The horizontal bars represent means. (D) Representative histological sections of colons 
stained with hematoxylin and eosin from the experiment summarized in C. Experimental groups are indicated (right), as well as injection with PBS or FL 
(top). Bars, 100 µm. (E) Histogram shows the mean absolute numbers ± SD of CD11chi MHCII+ DCs and CD4+CD25+Foxp3+ T reg cells in spleens from the 
RAG/ mice sacrificed 7 d after adoptive transfer that received the indicated cells and treatment.1860 DCS REGULATE T REG CELL HOMEOSTASIS AND TOLERANCE IN VIVO | Darrasse-Jèze et al.
cells were analyzed with a flow cytometer (LSR II; BD). Further analyses 
were performed with FlowJo software (Tree Star, Inc.). After adoptive trans-
fer in WT hosts under our experimental conditions (Fisson et al., 2003), 
donor T reg cells represented 0.1% of splenocytes. Therefore, 2–5 × 106 
events were acquired for each analysis.
CFSE staining and adoptive transfer of cells. MACS-sorted (Miltenyi 
Biotec) CD4+CD25+ or CD4+CD25 T cells or unfractionated cells from 
LN and spleens were labeled with CFSE (Sigma-Aldrich), as previously de-
scribed (Fisson et al., 2003), and transferred intravenously. Transferred cells 
were identified based on CD4, Foxp3, and CD45.1/2 expression.
DT-induced DC depletion in chimeric mice. DC depletion was per-
formed in CD11c-DTR BM chimeras. Recipient mice were irradiated with 
550 cGy plus 500 cGy, with 3 h between doses, and 8–16 × 106 BM cells 
were injected intravenously 3 h later. In the case of mixed chimeras, we used 
a 1:4 ratio of CD11c-DTR/C57BL/6 or MHCII/ BM. Mice were fed 
with antibiotic-supplemented food (TestDiet) and were given free access to 
water. Mice were used for experiments 8 wk after reconstitution. For DC 
depletion, recipients received injections of 1 µg DT from Corynebacterium 
diphtheriae (Sigma-Aldrich) intraperitoneally every 2–3 d for 6–18 d.
Isolation of lamina propria lymphocytes. Intestines were collected and 
flushed with ice-cold PBS, and Peyer’s patches were removed. Intestines 
were opened longitudinally and cut into 2–3-cm pieces. The pieces were 
washed once with cold PBS plus 1mM dithiothreitol and incubated twice in 
10 ml of 30 mM EDTA, 10 mM Hepes in PBS for 10 min at 37°C under 
slow rotation (150 rpm). The remaining tissue was washed once in complete 
RPMI 1640 medium (Invitrogen) supplemented with 10% FCS, and digested 
at 37°C for 90 min in complete RPMI 1640 containing collagenase (Sigma-
Aldrich) and 150 µg/ml DNase I (Roche). Digested tissue was passed 
through a 70-µm cell strainer. The flow-through was pelleted and subjected 
to a 40:80% Percoll gradient under centrifugation for 20 min at 2,500 rpm at 
room temperature. Lamina propria leukocytes were collected at the inter-
phase of the Percoll gradient, washed once, and resuspended in FACS buffer 
or complete RPMI 1640 medium. As lamina propria cell recovery from in-
flamed tissue is less efficient than from healthy intestine, only a proportion of 
different immune cells and not absolute numbers were assessed.
Intracellular  cytokine  staining. Cells obtained from the dissection of 
mesenteric LNs or lamina propria were incubated at 37°C for 7 h in 10%FCS 
complete RPMI 1640 medium with 50 ng/ml PMA (Sigma-Aldrich), 
750 ng/ml ionomycin (Sigma-Aldrich), and 1 µl/ml GolgiPlug (BD). Surface 
staining was performed for 30 min, after which the cells were resuspended in 
fixation/permeabilization solution (Cytofix/Cytoperm kit; BD). Intracellu-
lar cytokine staining using anti–IFN- and anti–IL-17 (BD) was performed 
according to the manufacturer’s protocol.
T reg cell depletion. T reg cells were depleted by intraperitoneal injection 
of 250 mg anti-CD25 mAb (clone PC61; produced by the Memorial Sloan-
Kettering Cancer Center/Rockefeller University monoclonal antibody core 
facility; Darrasse-Jèze et al., 2006).
Assessment of diabetes. Blood glucose levels were measured every week 
with a glucose meter (One Touch II; Lifescan). Mice were considered dia-
betic after three consecutive measurements >200 mg/dl. The onset of dia-
betes was dated from the first of the sequential diabetic measurements.
IBD model. LN and spleen CD4 T cells from C57BL/6 mice were purified 
by MACS using a CD4+ T cell isolation kit (Miltenyi Biotec). CD4+CD25hi 
(T reg) and CD4+CD25CD44int (naive Th) cells were purified by cell sort-
ing (BD; Fisson et al., 2003). 4 × 105 naive Th cells were injected alone or 
together with variable numbers of T reg cells. Weights were measured every 
week, and mice were sacrificed for histological evaluation of colitis, as previ-
ously described (Read and Powrie, 2001; Izcue et al., 2008).
MATERIALS AND METHODS
Mice, FL injection, oral gavage, and cell lines. FL/ and FLr/ mice 
were provided by I. Lemischka (The Black Family Stem Cell Institute at 
Mount Sinai School of Medicine, New York, NY; Mackarehtschian et al., 
1995) and H.J. McKenna (Fred Hutchinson Cancer Research Center, Seattle, 
WA; McKenna et al., 2000), respectively. Mice carrying a transgene encoding 
the DTR-GFP fusion protein under the control of the mouse CD11c pro-
moter (B6.FVB-Tg Itgax-DTR/GFP 57Lan/J or CD11c-DTR-GFP mice; 
a gift of S. Jung, The Weizmann Institute of Science, Rehovot, Israel) and 
Foxp3DTR-GFP mice that allow inducible ablation of DCs and T reg cells in 
vivo have been previously described (Jung et al., 2002; Kim et al., 2007). 
B cell–deficient mice (JH
/ mice; Chen et al., 1993)) were a gift from 
J. Ravetch (The Rockefeller University, New York, NY). CD11c-Cre mice 
(Caton et al., 2007) were a gift from B. Reizis (Columbia University Medical 
Center, New York, NY). I-Abflox mice have been previously described 
(iabneo/neo  mice;  Hashimoto  et  al.,  2002).  C57BL/6,  CD45.1+  (SJL), 
B6.RAG/, B6-MHCII/, and NOD mice came either from the Jackson 
Laboratory or were bred at the Rockefeller University. All mice were main-
tained in specific pathogen-free conditions. Mice compared in each experi-
ment were from the same commercial origin and were cohoused to minimize 
the influence of gut microflora (Ivanov et al., 2008). The experiments were 
conducted according to Rockefeller University Animal Care and Use Com-
mittee–approved protocols. rhFL was obtained from Amgen. rmFL was pro-
duced  by  anti-Flag–hemagglutinin  (HA)  purification  of  supernatant  from 
Chinese hamster ovary (CHO) cells expressing rmFLt-3L-FlagHA (a gift from 
C.G. Park, The Rockefeller University, New York, NY). The B16-FL tumor 
cell line was obtained from G. Dranoff (Dana-Farber Cancer Institute, Har-
vard Medical School, Boston, MA; Mach et al., 2000) and cultured in DMEM 
(Invitrogen) complemented with 10% FCS, 2 mM l-glutamine (Invitrogen), 
and 100 U/ml penicillin-streptomycin (Invitrogen). 106 tumor cells were in-
jected subcutaneously. All cell lines were mycoplasma free. Mice were ga-
vaged with 40 mg/kg sunitinib (Sutent; Pfizer) via feeding needles (Popper) 
once daily during the first 10 d of treatment and thereafter every 2 d.
Antibodies and flow cytometry analyses. The following mAbs were 
used:  anti-CD3  (2C11),  CD4  (RM4-5),  CD8  (53-6.7),  CD11c  (HL3), 
CD19 (1D3), CD25 (PC-61 or 7D4), CD44 (IM7), CD45.1 (A20), CD45.2 
(104), CD45R (RA3-6B2), CD135 (A2F10), MHCII (M5/114.15.2; from 
either BD or eBioscience), and PDCA1 (JFOS-1C2.4.1; Miltenyi Biotec). 
Intracellular labeling of the transcription factor Foxp3 by anti-Foxp3 anti-
body (FJK-16s; e-Bioscience) was performed according to the manufacturer’s 
recommendations. Isotype-irrelevant mAbs were used as controls. Processed 
Figure 5.  Proposed homeostatic feedback loop between DCs and 
T reg cells. Increased numbers of DCs result in increased numbers of 
T reg cells. An increase in T reg cells leads to a decrease in DCs, which in 
turn decreases the number of T reg cells, which then increases DCs. MHCII 
expression by DCs is required for these effects. A loss of T reg cells in-
creases DCs by a mechanism that requires FL.JEM VOL. 206, August 31, 2009  1861
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